{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:18:24Z","timestamp":1767212304927},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1007\/bf03343728","type":"journal-article","created":{"date-parts":[[2014,3,11]],"date-time":"2014-03-11T04:56:45Z","timestamp":1394513805000},"page":"310-316","source":"Crossref","is-referenced-by-count":11,"title":["Prevention of early postmenopausal bone loss with cyclical etidronate"],"prefix":"10.1007","volume":"23","author":[{"given":"S.","family":"Adami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Bruni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Becorpi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Campagnoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Marchesoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Balena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,11]]},"reference":[{"issue":"7968","key":"BF03343728_CR1","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","volume":"1","author":"R Lindsay","year":"1976","unstructured":"Lindsay R., Aitken J.M., Anderson J.B. Long-term prevention of postmenopausal osteoporosis by oestrogen. Lancet 1976, 1 (7968): 1038.","journal-title":"Lancet"},{"key":"BF03343728_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0140-6736(79)90640-8","volume":"2","author":"A Hutchinson","year":"1979","unstructured":"Hutchinson A., Polansky S.M., Feinstein A.R. Postmenopausal estrogens protect against fractures of the hip and distal radius: a case control study. Lancet 1979, 2: 705.","journal-title":"Lancet"},{"key":"BF03343728_CR3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJM198011203032102","volume":"303","author":"NS Weiss","year":"1980","unstructured":"Weiss N.S., Ure C.L., Ballard J.H., Williams A.R., Daling J.R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogens. N. Engl. J. Med. 1980, 303: 1195\u20131198.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR4","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/0003-4819-102-3-319","volume":"102","author":"B Ettinger","year":"1985","unstructured":"Ettinger B., Genant H.K., Cann C.E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann. Int. Med. 1985, 102: 319\u2013324.","journal-title":"Ann. Int. Med."},{"key":"BF03343728_CR5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1056\/NEJM198711053171901","volume":"317","author":"DP Kiel","year":"1987","unstructured":"Kiel D.P., Felson D.T., Anderson J.J., Wilson P.W.F., Moskowitz M.A. Hip fracture and the use of estrogens in post-menopausal women: the Framingham study. N. Engl. J. Med. 1987, 317: 1169\u20131174.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","volume":"117","author":"EG Lufkin","year":"1992","unstructured":"Lufkin E.G., Wahner H.W., O\u2019Fallon W.M., Hodgsons S.F., Kotowicz M.A., Lane A.W., Judd H.L., Caplan R.H., Riggs B.L. Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann. Intern. Med. 1992, 117: 1\u20139.","journal-title":"Ann. Intern. Med."},{"key":"BF03343728_CR7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin J.H. Bisphosphonates: a review of their pharmacokinetic properties. Bone 1996, 18: 75\u201385.","journal-title":"Bone"},{"key":"BF03343728_CR8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJM199005033221803","volume":"322","author":"T Storm","year":"1990","unstructured":"Storm T., Thamsborg G., Steiniche T., Genant H.K., S\u00f8rensen O.H. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with post-menopausal osteoporosis. N. Engl. J. Med. 1990, 322: 1265\u20131271.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1056\/NEJM199007123230201","volume":"323","author":"NB Watts","year":"1990","unstructured":"Watts N.B., Harris S.T., Genant H.K., Wasnich R.D., Miller P.D., Jackson R.D., Licata A.A., Ross P., Woodson G.C., Yanover M.J., Mysiw W.J., Kohse L., Rao M.B., Steiger P., Richmond B., Chesnut C.H. Intermittent cyclical etidronate treatment of post-menopausal osteoporosis. N. Engl. J. Med. 1990, 323: 72\u201379.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR10","first-page":"1560","volume":"23","author":"T Storm","year":"1996","unstructured":"Storm T., Kollerup G., Thamsborg G., Genant H.K., S\u00f8rensen O.H. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis. J. Rheumatol. 1996, 23: 1560\u20131564.","journal-title":"J. Rheumatol."},{"key":"BF03343728_CR11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","volume":"337","author":"JD Adachi","year":"1997","unstructured":"Adachi J.D., Bensen W.G., Brown J., Hanley D., Hodsman A., Josse R.J., Kendler D.L., Lentle B., Olszynski W., Ste.-Marie L.G., Tenenhouse A., Chines A.A. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N. Engl. J. Med. 1997, 337: 382\u2013387.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR12","first-page":"2784","volume":"82","author":"PJ Meunier","year":"1997","unstructured":"Meunier P.J., Confavreux E., Tupinon I., Hardouin C., Delmas P.D., Balena R. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up). J. Clin. Endocrinol. Metab. 1997, 82: 2784\u20132791.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03343728_CR13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01622291","volume":"7","author":"JM Pouilles","year":"1977","unstructured":"Pouilles J.M., Tremollieres F., Roux C., Sebert J.L., Alexandre C., Goldberg D., Treves R., Khalifa P., Duntze P., Horlait S., Delmas P., Kuntz D. Effects of cyclical etidronate therapy on bone loss in early postmenopausal women who are not undergoing hormonal replacement therapy. Osteoporos. Int. 1977, 7: 213.","journal-title":"Osteoporos. Int."},{"issue":"5","key":"BF03343728_CR14","volume":"23","year":"1998","unstructured":"Adami S., Ottanelli S., Lombardi P., Campagnoli C., Ferrari A., Marchesoni D., Balena R. Prevention of early postmenopausal bone loss with cyclical etidronate: a double-blind, placebo-con trolled study. Bone 1998, 23 (5): (Suppl.).","journal-title":"Bone"},{"key":"BF03343728_CR15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF01623376","volume":"3","author":"RA Evans","year":"1993","unstructured":"Evans R.A., Somers N.M., Dunstan C.R., Royle H., Kos S. The effect of low-dose cyclical etidronate and calcium on bone mass in early postmenopausal women. Osteoporos. Int. 1993, 3: 71\u201375.","journal-title":"Osteoporos. Int."},{"key":"BF03343728_CR16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0002-9343(97)00019-3","volume":"103","author":"RJM Herd","year":"1997","unstructured":"Herd R.J.M., Balena R., Blake G.M., Ryan P.J., Fogelman I. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study. Am. J. Med. 1997, 103: 92\u201399.","journal-title":"Am. J. Med."},{"key":"BF03343728_CR17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/jbmr.5650101124","volume":"10","author":"NFA Peel","year":"1995","unstructured":"Peel N.F.A., Eastell R. Comparison of rates of bone loss from the spine measured using two manufacturers\u2019 densitometers. J. Bone Miner. Res. 1995, 10: 1796\u20131801.","journal-title":"J. Bone Miner. Res."},{"key":"BF03343728_CR18","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199706193362501","volume":"336","author":"F Grodstein","year":"1997","unstructured":"Grodstein F., Stampfer M.J., Colditz G.A., Willett W.C., Manson J., Joffe M., Rosner B., Fuchs C., Hankinson S.E., Hunter D.J., Hennekens C.H., Speizer F.E. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 1997, 336: 1769\u20131775.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1212\/WNL.48.6.1517","volume":"48","author":"C Kawas","year":"1997","unstructured":"Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Longle D.D., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer\u2019s disease: The Baltimore Longitudinal Study of Aging. Neurology 1997, 48: 1517\u20131521.","journal-title":"Neurology"},{"key":"BF03343728_CR20","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM199506153322401","volume":"332","author":"GA Colditz","year":"1995","unstructured":"Colditz G.A., Hankinson S.E., Hunter D.J., Willett W.C., Manson J., Stampfer M.J., Hennekens C., Rosner B., Speizer F.E. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 1995, 332: 1589\u20131593.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR21","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(97)08233-0","volume":"350","author":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast Cancerhormone replacement therapy.","year":"1997","unstructured":"Collaborative Group on Hormonal Factors in Breast Cancer: Breast Cancer and hormone replacement therapy. Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997, 350: 1047\u20131059.","journal-title":"Lancet"},{"key":"BF03343728_CR22","first-page":"583","volume-title":"Osteoporosis. Bailliere\u2019s Clinical Rheumatology","author":"JE Compston","year":"1997","unstructured":"Compston J.E. Hormone replacement therapy. In: Delmas P.D., Woolf A.D. (Eds.), Osteoporosis. Bailliere\u2019s Clinical Rheumatology, 1997, pp. 583\u2013596."},{"key":"BF03343728_CR23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1359-6446(97)01134-3","volume":"3","author":"JA Yates","year":"1998","unstructured":"Yates J.A., Roden G.A. Alendronate and osteoporosis. DDT 1998, 3: 69.","journal-title":"DDT"},{"key":"BF03343728_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJM199802193380801","volume":"338","author":"D Hosking","year":"1998","unstructured":"Hosking D., Chilvers C., Christiansen C., Ravn P., Wasnich R., Ross P., McClung M., Balske A., Thompson D., Daley M., Yates J.A. Prevention of bone loss with alendronate in post-menopausal women under 60 yeas of age. N. Engl J. Med. 1998, 338: 485.","journal-title":"N. Engl J. Med."},{"key":"BF03343728_CR25","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJM199610033351403","volume":"335","author":"PC Groen De","year":"1996","unstructured":"De Groen P.C., Lubbe D.F., Hirsch L.J., Daifotis A., Stephenson W., Freedholm D., Pryor-Tillotson S., Seleznick M.J., Pinkas H., Wang K.K. Esophagitis associated with the use of alendronate. N. Engl. J. Med. 1996, 335: 1016\u20131021.","journal-title":"N. Engl. J. Med."},{"key":"BF03343728_CR26","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S0002-9343(97)00242-8","volume":"103","author":"T Staa Van","year":"1997","unstructured":"Van Staa T. Upper gastrointestinal adverse events and cyclical etidronate. Am. J. Med. 1997, 103: 462.","journal-title":"Am. J. Med."},{"key":"BF03343728_CR27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/rheumatology\/37.1.87","volume":"37","author":"TP Staa Van","year":"1998","unstructured":"Van Staa T.P., Abenhaim L., Cooper C. Use of cyclical etidronate and prevention of non-vertebral fractures. Br. J. Rheumatol. 1998, 37: 87\u201394.","journal-title":"Br. J. Rheumatol."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343728.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03343728\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03343728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T06:26:10Z","timestamp":1558506370000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03343728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["BF03343728"],"URL":"https:\/\/doi.org\/10.1007\/bf03343728","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}